Social Network
FDA extends review process for Novartis drug by three months
June 04 2020, 08:00
The review process for a drug to treat patients with relapsing multiple sclerosis was extended by three months.
Source: FOX News
Back to news
Related news
Nick Reiner's defense attorney weighs insanity plea as murder case enters discovery phase, legal expert says
2025 lookback: Trump yanks federal funding from NPR in move conservative advocates said was long overdue
Prince Harry, Meghan Markle face slim path to reconciling with their ailing fathers, heal family feud: experts
Ex-NASCAR star Greg Biffle's deadly plane crash recalls several aviation tragedies to hit sports world
Family of victim and survivors of Indianapolis FedEx mass shooting file lawsuit against gun magazine manufacturer and distributors
Tennessee Air National Guardsman applied to be a hitman online, the FBI says. It was a spoof website and now he's facing charges
Fulton County, Georgia, jail leadership resigns after inmate's death and accusations of unsanitary conditions
Big-box stores could help slash emissions and save millions by putting solar panels on roofs. Why aren't more of them doing it?
Not only is Lake Powell's water level plummeting because of drought, its total capacity is shrinking, too
US Catholic bishops president says deportations instilling 'fear' in 'widespread manner': 'Concerns us all'